Palisade Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.86

+0.11 (+6.29%)

As of Apr 1, 2:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +136.6% upside

Low Target $2.36

Average Target $4.40

High Target $4.89

Current Price $1.86

Current
$1.86

Target
$4.40

$2.36 $4.40 avg $4.89

Scenario Analysis

Bear Case

$2.36

26.9%

Low target

Base Case

$4.40

+136.6%

Avg target

Bull Case

$4.89

+162.9%

High target

Risk/Reward

6.1x

Highly favorable

Price in Context

52-Week High

$2.64

-29.5% from high

52-Week Low

$0.53

+250.9% from low

Target vs 52W High

$4.40

+66.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%